Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C

被引:0
作者
Takata, Kazuhide [1 ]
Ishii, Fuminori [2 ]
Uchida, Yotaro [1 ]
Fukuda, Hiromi [1 ]
Yamauchi, Ryo [1 ]
Umeda, Kaoru [1 ]
Tsuchiya, Naoaki [1 ]
Tanaka, Takashi [1 ]
Yokoyama, Keiji [1 ]
Morihara, Daisuke [1 ]
Takeyama, Yasuaki [1 ]
Shakado, Satoshi [1 ]
Sakisaka, Shotaro [1 ]
Hirai, Fumihito [1 ]
机构
[1] Fukuoka Univ, Dept Gastroenterol & Med, Fac Med, Fukuoka, Japan
[2] Fukuoka Univ, Dept Gastroenterol Surg, Fac Med, Fukuoka, Japan
关键词
hepatocellular carcinoma; interferon therapy; sustained virologic response; RECURRENCE; RISK;
D O I
10.2169/internalmedicine.4479-20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of hepatocellular carcinoma (HCC) after a sustained virologic response (SVR) due to interferon (IFN) therapy for hepatitis C virus infection remains a serious problem. We herein report 2 cases of HCC that developed more than 20 years after SVR with IFN therapy for chronic hepatitis C. The patients were 89- and 72-year-old men with HCC that developed 24-25 years after an SVR with IFN therapy. These patients regularly underwent imaging examinations; therefore, the HCC was detected in the early stage, when it was still curable. Both cases suggest that long-term surveillance after an SVR is effective for the detection of HCC, and radical treatment is possible.
引用
收藏
页码:1855 / 1860
页数:6
相关论文
共 50 条
[41]   Type C chronic hepatitis with the discovery of a small hepatocellular carcinoma 7 years after successful interferon therapy [J].
Tomimatsu, M ;
Endo, H ;
Kitazawa, M ;
Iga, D ;
Fujimoto, T ;
Ohkawa, SI ;
Kajiyama, H ;
Katagiri, S ;
Harada, N ;
Yamamoto, M ;
Takasaki, K .
JOURNAL OF GASTROENTEROLOGY, 2003, 38 (04) :395-398
[42]   A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C-Associated Liver Cirrhosis [J].
Aleman, Soo ;
Rahbin, Nogol ;
Weiland, Ola ;
Davidsdottir, Loa ;
Hedenstierna, Magnus ;
Rose, Nina ;
Verbaan, Hans ;
Stal, Per ;
Carlsson, Tony ;
Norrgren, Hans ;
Ekbom, Anders ;
Granath, Fredrik ;
Hultcrantz, Rolf .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (02) :230-236
[43]   A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy [J].
Chang, Kuo-Chin ;
Hung, Chao-Hung ;
Lu, Sheng-Nan ;
Wang, Jing-Houng ;
Lee, Chuan-Mo ;
Chen, Chien-Hung ;
Yen, Ming-Fang ;
Lin, Sheng-Chieh ;
Yen, Yi-Hao ;
Tsai, Ming-Chao ;
Tseng, Po-Lin ;
Hu, Tsung-Hui .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (11) :2766-2772
[44]   aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C [J].
Yamashita, Yuki ;
Joshita, Satoru ;
Sugiura, Ayumi ;
Yamazaki, Tomoo ;
Kobayashi, Hiroyuki ;
Wakabayashi, Shun-ichi ;
Yamada, Yosuke ;
Shibata, Soichiro ;
Kunimoto, Hideo ;
Iwadare, Takanobu ;
Matsumura, Makiko ;
Miyabayashi, Chiharu ;
Okumura, Taiki ;
Ozawa, Sachie ;
Nozawa, Yuichi ;
Kobayashi, Natsuko ;
Komatsu, Michiharu ;
Fujimori, Naoyuki ;
Saito, Hiromi ;
Umemura, Takeji .
HEPATOLOGY RESEARCH, 2021, 51 (09) :933-942
[45]   Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis [J].
Zangneh, Hooman Farhang ;
Wong, William W. L. ;
Sander, Beate ;
Bell, Chaim M. ;
Mumtaz, Khalid ;
Kowgier, Matthew ;
van der Meer, Adriaan J. ;
Cleary, Sean P. ;
Janssen, Harry L. A. ;
Chan, Kelvin K. W. ;
Feld, Jordan J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) :1840-+
[46]   Development of hepatocellular carcinoma in a patient with chronic hepatitis C after 6 years of a sustained and complete response to IFN-α [J].
Yamaguchi, K ;
Omagari, K ;
Kinoshita, H ;
Yoshioka, S ;
Furusu, H ;
Takeshima, F ;
Nanashima, A ;
Yamaguchi, H ;
Kohno, S .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1999, 29 (02) :207-209
[47]   Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders [J].
Imai, Y. ;
Tamura, S. ;
Tanaka, H. ;
Hiramatsu, N. ;
Kiso, S. ;
Doi, Y. ;
Inada, M. ;
Nagase, T. ;
Kitada, T. ;
Imanaka, K. ;
Fukuda, K. ;
Takehara, T. ;
Kasahara, A. ;
Hayashi, N. .
JOURNAL OF VIRAL HEPATITIS, 2010, 17 (03) :185-191
[48]   Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin [J].
Ng, Khai-Jing ;
Tseng, Chih-Wei ;
Chang, Ting-Tsung ;
Tzeng, Shinn-Jia ;
Hsieh, Yu-Hsi ;
Hung, Tsung-Hsing ;
Huang, Hsiang-Ting ;
Wu, Shu-Fen ;
Tseng, Kuo-Chih .
CLINICAL INTERVENTIONS IN AGING, 2016, 11 :1035-1041
[49]   Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients [J].
Merchante, Nicolas ;
Rodriguez-Arrondo, Francisco ;
Revollo, Boris ;
Merino, Esperanza ;
Ibarra, Sofia ;
Galindo, Maria J. ;
Montero, Marta ;
Garcia-Deltoro, Miguel ;
Rivero-Juarez, Antonio ;
Tellez, Francisco ;
Delgado-Fernandez, Marcial ;
Rios-Villegas, Maria J. ;
Garcia, Maria A. ;
Vera-Mendez, Francisco J. ;
Ojeda-Burgos, Guillermo ;
Lopez-Ruz, Miguel A. ;
Metola, Luis ;
Omar, Mohamed ;
Remedios Aleman-Valls, Maria ;
Aguirrebengoa, Koldo ;
Portu, Joseba ;
Raffo, Miguel ;
Macias, Juan ;
Pineda, Juan A. .
AIDS, 2018, 32 (11) :1423-1430
[50]   Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response [J].
Muecke, Victoria T. ;
Thomas, Dominique ;
Muecke, Marcus M. ;
Waidmann, Oliver ;
Zeuzem, Stefan ;
Sarrazin, Christoph ;
Pfeilschifter, Josef ;
Vermehren, Johannes ;
Finkelmeier, Fabian ;
Grammatikos, Georgios .
LIVER INTERNATIONAL, 2019, 39 (11) :2174-2183